+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review

  • ID: 4429803
  • SWOT Analysis
  • March 2019
  • Region: Global
  • 51 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Athersys Inc
  • Cytori Therapeutics Inc
  • GenVec, Inc.
  • Juventas Therapeutics Inc
  • Nuo Therapeutics Inc
  • Osiris Therapeutics Inc
  • MORE
Cesca Therapeutics Inc (KOOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. Cesca is headquartered in Rancho Cordova, California, the US.

Cesca Therapeutics Inc Key Recent Developments

Mar 25, 2019 Cesca Therapeutics announces fiscal 2018 year end financial results and provides corporate update
Jan 21, 2019 ThermoGenesis completes construction and qualification of in-house clean room for assembly of all X-Series cell processing disposables
Nov 19, 2018 Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP II AutoXpress Platform for Clinical Cord Blood Banking
Nov 14, 2018 Cesca Therapeutics Reports Third Quarter 2018 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Athersys Inc
  • Cytori Therapeutics Inc
  • GenVec, Inc.
  • Juventas Therapeutics Inc
  • Nuo Therapeutics Inc
  • Osiris Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Cesca Therapeutics Inc - Key Facts
  • Cesca Therapeutics Inc - Key Employees
  • Cesca Therapeutics Inc - Key Employee Biographies
  • Cesca Therapeutics Inc - Major Products and Services
  • Cesca Therapeutics Inc - History
  • Cesca Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Cesca Therapeutics Inc - Business Description
  • R&D Overview
  • Cesca Therapeutics Inc - Corporate Strategy
  • Cesca Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cesca Therapeutics Inc - Strengths
  • Cesca Therapeutics Inc - Weaknesses
  • Cesca Therapeutics Inc - Opportunities
  • Cesca Therapeutics Inc - Threats
  • Cesca Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Cesca Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Cesca Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 25, 2019: Cesca Therapeutics announces fiscal 2018 year end financial results and provides corporate update
  • Jan 21, 2019: ThermoGenesis completes construction and qualification of in-house clean room for assembly of all X-Series cell processing disposables
  • Nov 19, 2018: Cesca Therapeutics Receives 510(k) Clearance to Market Its AXP II AutoXpress Platform for Clinical Cord Blood Banking
  • Nov 14, 2018: Cesca Therapeutics Reports Third Quarter 2018 Financial Results
  • Oct 16, 2018: Cesca Therapeutics announces cost reduction measures aimed at achieving cash flow positive position in 2019
  • Sep 30, 2018: Cesca Therapeutics To Announce Financial Results For The Third Quarter Ended September 30, 2018 And Host Conference Call On November 14
  • Sep 05, 2018: Cesca Therapeutics provides commercialization update for its X-Series product line
  • Aug 29, 2018: Cesca Therapeutics announces poster presentation at the 4th annual CAR-TCR Summit
  • Aug 13, 2018: Cesca Therapeutics announces second quarter 2018 financial results and provides corporate update
  • Jun 04, 2018: Cesca Therapeutics Announces Reduction in Operating Expenses
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Cesca Therapeutics Inc, Key Facts
  • Cesca Therapeutics Inc, Key Employees
  • Cesca Therapeutics Inc, Key Employee Biographies
  • Cesca Therapeutics Inc, Major Products and Services
  • Cesca Therapeutics Inc, History
  • Cesca Therapeutics Inc, Other Locations
  • Cesca Therapeutics Inc, Subsidiaries
  • Cesca Therapeutics Inc, Key Competitors
  • Cesca Therapeutics Inc, Ratios based on current share price
  • Cesca Therapeutics Inc, Annual Ratios
  • Cesca Therapeutics Inc, Annual Ratios (Cont...1)
  • Cesca Therapeutics Inc, Interim Ratios
  • Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Cesca Therapeutics Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Cesca Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cesca Therapeutics Inc, Performance Chart (2013 - 2017)
  • Cesca Therapeutics Inc, Ratio Charts
  • Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Cesca Therapeutics Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 3
  • Vericel Corp
  • U.S. Stem Cell Inc
  • Tissue Genesis Inc
  • Osiris Therapeutics Inc
  • Nuo Therapeutics Inc
  • Juventas Therapeutics Inc
  • GenVec, Inc.
  • Cytori Therapeutics Inc
  • Athersys Inc
Note: Product cover images may vary from those shown
Adroll
adroll